JULY 2013 • Vol. 2, Issue 3


Alliance for MRI Shares Important News in Europe

Helle Juhl Simonsen, MRT
Chair, Global Relations

“After almost 10 years of uncertainty, the Members of the European Parliament today took the step to ensure continued patient access to MRI...”

European Parliament approves important changes to European health and safety legislation enabling continued access to Magnetic Resonance Imaging (MRI) technology for patients in Europe.

Background

The Alliance for MRI is a coalition of European Parliamentarians, patient groups, leading European scientists and the medical community, who together are seeking to avert the serious threat posed by EU health and safety legislation to the clinical use of, and research into, magnetic resonance imaging (MRI).

The Alliance for MRI was officially launched in March 2007 in response to the pending implementation of the EU Physical Agents 2004/40/EC (on electromagnetic fields) in April 2008. The Alliance was founded by the European Society of Radiology, the European Federation of Neurological Associations and Dr. Hannes Swoboda MEP, Chair of the Socialist Group in the European Parliament.

In October 2007, the European Commission proposed extending the implementation deadline from April 2008 to April 2012, to allow more time for the evaluation of new data on electromagnetic fields and their short-term effects on the human body. As a result, the European Commission published a new proposal in June 2011 revising Directive 2004/40/EC in order to exempt MRI from the exposure limit values. The MRI safety is already ensured through the MR safety standard IEC/EN 60601-2-33 (harmonised through the European Medical Devices Directives) which defines criteria for minimising physiological effects due to exposure to time-varying electromagnetic fields for patients and workers.

MRI is a diagnostic technique that uses radio and magnetic waves to produce images of unrivalled quality, particularly of soft tissues that are not well depicted using X-rays. It is essential for the diagnosis and treatment of life-threatening diseases such as cancer, heart disease and brain disorders. MRI is used for mapping brain functions prior to surgery for diseases such as epilepsy and to advance our understanding of how the brain works. New cutting-edge diagnostic and treatment techniques such as MRI-guided surgery are constantly being developed, leading to improved patient outcomes.

The Alliance for MRI welcomes the European Parliament's approval of a derogation for Magnetic Resonance Imaging (MRI) in its draft report on the revised 2004/40/EC Directive on Protecting Workers from Exposure to Electromagnetic Fields (EMF Directive).
This derogation is necessary to ensure the unimpeded use of MRI so that patients have access to the highest standard of care across Europe. The safe use of this technology is highly regulated. Criteria have been set to eliminate any danger to workers and patients.

MRI has been used for almost 30 years, imaging to well over 600 million patients without evidence of harm to workers due to exposure to electromagnetic fields. The Alliance supports the adoption of guidelines to ensure that working practices are in line with the latest technological developments.

On 14 June 2011 the European Commission adopted a proposal to revise the directive on protecting workers from electromagnetic fields. The European Commission's proposal includes a derogation for the medical and research use of MRI from the exposure limit values, which will ensure that this vital technology will continue to be available for all patients. Two years later, on 11 June 2013 the European Parliament adopted the report on the revised Directive on Protecting Workers from Exposure to Electromagnetic Fields including the derogation for Magnetic Resonance Imaging (MRI) with 594 votes in favour out of 672 and 38 abstentions.

The adoption is in line with the First Reading Political Agreement concluded by Council and Parliament in April 2013, following intense informal discussions after the European Parliament's Employment and Social Affairs (EMPL) Committee vote in December 2012.

After almost 10 years of uncertainty, the Members of the European Parliament today took the step to ensure continued patient access to MRI by endorsing the MRI derogation in its adoption of the report on the revised Directive 2004/40/EC on electromagnetic fields. This is a result of the concerns raised by the Alliance for MRI that the 2004/40/EC Directive severely curtailed the use of MRI to the detriment of patients in Europe.

It was really good news for both patients and for who us work with MRI.

http://www.alliance-for-mri.org/cms/website.php?id=/en/eu_affairs_research/alliance_for_mri.htm